Blog

Indication
Secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis
Hypercalcemia in patients with Parathyroid carcinoma and primary hyperparathyroidism (HPT)
Sideeffects
Dizziness, headache
Nausea or vomiting
Constipation
Feeling weak
Mechanisam of action
PTH 30MG contains cinacalcet which belongs to a group of medicines called calcimimetic agent that increases the sensitivity of the calcium-sensing receptor to activation by extracellular calcium. It treats problem with the organs called parathyroid glands. The parathyroids are four small glands in the neck, near thyroid gland, that produce the parathyroid hormone (PTH). Hyperparathyroidism (HPT) is a condition where the parathyroid gland may become overactive and make too much PTH. In this condition the calcium stored in the bones move into the blood leading to hypercalcemia (too much calcium in the blood).

Secondary hyperparathyroidism (SHPT) describes an alteration in bone and mineral metabolism that occurs as a direct result of chronic kidney disease (CKD). The parathyroid gland is the central organ responsible for regulating these adaptive responses leading to secondary hyperparathyroidism. Parathyroid hormone helps prevent low calcium levels by acting on the bones, intestine, and kidneys. PTH 30MG works by controlling levels of the parathyroid hormone (PTH), calcium and phosphorous in body.